This site is intended for healthcare professionals only
LoginRegister
GST Department Launches Search, Inspection at Ciplas Maharashtra FacilitiesCipla gets CDSCO Panel nod for Phase-III CT of Inhaled Itraconazole dry powder for inhalation 10 mg...
Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCoMankind Pharma to constitute committee to evaluate ways to integrate BSV
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Biologics secures market entry date for ophthalmology drug Yesafili in US
AstraZeneca Pharma India surrenders marketing authorisation for specific indication of OlaparibAstraZeneca Pharma India surrenders marketing authorisation for specific indication of Olaparib
Amid Global Headwinds, Brazil and Nigeria Fuel Indias Pharma Export GrowthDelhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare...
JnJ Medtech bags USFDA nod for TRUFILL n-BCA Liquid Embolic System for Symptomatic Chronic Subdural HematomaJohnson & Johnson MedTech completes first cases with OTTAVA Robotic Surgical System
Whos going to pay price to bring back manufacturing in US, asks Biocon MD"Who's going to pay price to bring back manufacturing in US", asks Biocon MD
Dr Reddys Foils Email Spoofing Scam, Rs 2.16 Cr Recovered by Bengaluru PoliceRs 1 Cr Plus Earners in Firing Line as Dr Reddy's Targets 25% Cost Cut, May Shut Digital Unit
PCI Directs Examining Authorities to Mandatorily Register on Portal by Feb 21PCI Issues Special Inspection Guidelines for 2025-2026 academic session
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, GemcitabineNPPA fixes retail prices of 80 formulations, Details
Pfizer discontinues development of danuglipron for chronic weight managementPfizer discontinues development of danuglipron for chronic weight management
Multi-drug resistant infections medicine Zaynich to get USFDA approval next year: Wockhardt ChairmanMulti-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt...
X